Sunesis raises $45mm with private placement
Executive Summary
Sunesis Pharmaceuticals (small-molecule oncology therapeutics) has raised $45mm from a private placement. It sold 7.25mm common shares--that carry warrants to buy an additional 2.17mm common--for $6.21 each (a 7% premium to the market average). Investors, including Deerfield Management, Baker Brothers Investments, funds managed by Alta Partners, and existing backer Warburg Pincus, paid an additional $0.125 for each share underlying the warrants (equal to $271,250). Cowen & Co. acted as the placement agent.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice